Evidence map›Paper›PMID 37937828›Full record

ArticleeLife2023

Melanopsin activates divergent phototransduction pathways in intrinsically photosensitive retinal ganglion cell subtypes.

Ely Contreras, Jacob D Bhoi, Takuma Sonoda, Lutz Birnbaumer, Tiffany M Schmidt

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Atypical Retinal Ganglion Cell Function in a Mouse Model of Fragile X Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  6. Flp-recombinase mouse line for genetic manipulation of ipRGCs.bioRxiv : the preprint server for biology · 2024
    Article
  7. Coexistence within one cell of microvillous and ciliary phototransductions across M1- through M6-IpRGCs.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Ely ContrerasDepartment of Neurobiology, Northwestern University, Evanston, United States.ORCID 0000-0003-3684-5817
Jacob D BhoiDepartment of Neurobiology, Northwestern University, Evanston, United States.ORCID 0000-0002-5952-367X
Takuma SonodaDepartment of Neurobiology, Northwestern University, Evanston, United States.
Lutz BirnbaumerLaboratory of Signal Transduction, National Institute of Environmental Health Sciences, Durham, United States.
Tiffany M SchmidtDepartment of Neurobiology, Northwestern University, Evanston, United States.ORCID 0000-0002-4791-6775
Northwestern University · PHNorthwestern University · USPontificia Universidad Católica Argentina · AR

Funding

TRAINING GRANT IN SLEEP RESEARCHT32HL007909 · NHLBI · NORTHWESTERN UNIVERSITY · PI FRED W TUREK, Phyllis C. Zee · 1998 to 2026
$9.2M
Genetic mapping of visual circuitsDP2EY027983 · NEI · NORTHWESTERN UNIVERSITY · PI SCHMIDT, TIFFANY M. · 2016 to 2019
$2.7M
Non-canonical GABAergic Pathways in the Visual SystemR01EY030565 · NEI · NORTHWESTERN UNIVERSITY · PI SCHMIDT, TIFFANY M. · 2020 to 2024
$2.6M
Transmembrane Signaling Mechanisms Involving TRP ChannelsZ01ES101684 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BIRNBAUMER, LUTZ · 2003 to 2008
$2.1M
Visual Sciences T32T32EY025202 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Gregory William Schwartz · 2015 to 2026
$1.4M
GABAergic Retinal Ganglion Cells in the Mammalian RetinaF31EY030360 · NEI · NORTHWESTERN UNIVERSITY · PI SONODA, TAKUMA · 2019 to 2019
$36k
Intramural NIH HHS Z01 ES101684NEI NIH HHS DP2 EY027983NEI NIH HHS DP2EY027983NEI NIH HHS F31 EY030360NEI NIH HHS F31EY030360NEI NIH HHS R01 EY030565NEI NIH HHS R01EY030565NEI NIH HHS T32 EY025202NEI NIH HHS T32EY025202NHLBI NIH HHS T32 HL007909NIH HHS Z01-ES-101684
6 · The paper itself

Abstract

Melanopsin signaling within intrinsically photosensitive retinal ganglion cell (ipRGC) subtypes impacts a broad range of behaviors from circadian photoentrainment to conscious visual perception. Yet, how melanopsin phototransduction within M1-M6 ipRGC subtypes impacts cellular signaling to drive diverse behaviors is still largely unresolved. The identity of the phototransduction channels in each subtype is key to understanding this central question but has remained controversial. In this study, we resolve two opposing models of M4 phototransduction, demonstrating that hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are dispensable for this process and providing support for a pathway involving melanopsin-dependent potassium channel closure and canonical transient receptor potential (TRPC) channel opening. Surprisingly, we find that HCN channels are likewise dispensable for M2 phototransduction, contradicting the current model. We instead show that M2 phototransduction requires TRPC channels in conjunction with T-type voltage-gated calcium channels, identifying a novel melanopsin phototransduction target. Collectively, this work resolves key discrepancies in our understanding of ipRGC phototransduction pathways in multiple subtypes and adds to mounting evidence that ipRGC subtypes employ diverse phototransduction cascades to fine-tune cellular responses for downstream behaviors.

Indexed as

Light Signal TransductionRetinal Ganglion CellsRod OpsinsAnimalsHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMelanopsinMiceVision, OcularHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMelanopsinRod Opsinsganglion cellipRGCMelanopsinmouseneuroscienceretinatransductionTRP channel

Identifiers

PMID37937828
PMCPMC10712949
OpenAlexW4388491621

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.